| Drug Class: | Aromatase Inhibitor; Antiestrogen |
| Pharmaceutical Name: | Fempro |
| Chemical Name: | Letrozole |
| Chemical Abstract Name: | 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile |
| Molecular Structure: | C17H11N5 |
| Molecular Weight: | 285.303 g/mol |
| Active Half Life: | 2 Days |
| Dosage: | 0.5-2.5 mg/day |
| Acne: | No |
| Water retention: | No |
| High blood pressure: | No |
| Hepatotoxicity: | No |
| Aromatization: | No |
| Hypothalamus-Pituitary-Testes-Axis suppression: | None |
| Manufacturer: | Cipla |
| Country: | India |
| Presentation: | Fempro for sale - 1 x 50 tabs х 2.5 mg |
Commercial Names: Oreta, Mamazol, Letrozol, Zaronil, Fempro, Feofar, Letros, Fematroz, Letrova, Letrazole, Letronat, Letroz, Lets, Oncolet, Shantroz, Letromina, Femara, Letzol, Trozet, Letocor, Feofer, Letoval, Letoripe, Letroxyl, Letz, Momazol.
Please log in to write Fempro review.